Exclusive
Exclusive
Exclusive
Deep Lens Raises $14 million to Improve AI-driven Pathology (Interview)
Deep Lens is an AI-driven digital pathology company based in Ohio. They’re currently working with Worldwide Clinical Trials to fast-track patient enrollment into clinical trials. This week, they announced a successful Series A financing round of...
Exclusive
Our Visit to WIRED Health 2019 at London’s Francis Crick Institute
WIRED Health, now in its sixth year, returned to London’s Francis Crick Institute. The event was opened by Crick Institute director Paul Nurse who introduced the institute and its mission to understand the fundamental biology of human health...
Exclusive
Aktiia's Cuffless Blood Pressure Monitor is Accurate for Months
It doesn't need recalibrating often. The Aktiia optical blood pressure monitor was tested in six healthy volunteers and agreed with a traditional inflating-cuff blood pressure monitor (Omron M6) two months after the initial calibration. The...
Exclusive
The iovera° Cryoanalgesia Device: Interview with Tim Still, CEO of Myoscience
Myoscience, a medtech company based in California, has developed the iovera° cryoanalgesia device. The device was FDA cleared in 2013, with an additional clearance in 2017 for knee pain, and uses cryotherapy to freeze peripheral nerves to reduce...
Exclusive
Philips Azurion with FlexArm for Enhanced Image-Guided Therapy: Interview with Dr. Barry Katzen of Miami Cardiac and Vascular Institute
Philips recently announced the release of an enhancement to its Azurion imaging system – the FlexArm. Developed in partnership with the Miami Cardiac & Vascular Institute, the technology allows a clinician to image a patient from every...
Exclusive
Future Healthcare 2019: A Medgadget Report
Future Healthcare 2019 came to London’s Olympia with a two-day exhibition and conference featuring speakers from industry, the clinical setting, and a strong showing of start-up companies. The event was opened by former UK Secretary of Health...
Exclusive
Interview with Tom Reeves, CEO of Interface Biologics
Interface Biologics Inc (IBI) is a company from Toronto, Ontario, Canada that develops innovative materials for both Medtech and Pharmaceutical applications. Their Surface Modification Technology is called Endexo, which are fluorine-based additives...
Exclusive
CareAlert, A Non-Intrusive Home Monitoring System: Interview with Fereydoun Taslimi, CEO of SensorsCall
The world’s aging population continues to grow. Today, in the U.S. alone, there are more than 46 million people 65 years and older, accounting for around 15 percent of the population. This is expected to swell to 20 percent by the year...
Exclusive
Diagnosing Esophageal Cancer More Accurately: Interview with Mark Rutenberg, CEO of CDx Diagnostics
Cancer of the esophagus is often related to chronic heartburn, something patients too often end up ignoring. The onset of the potentially deadly disease can be detected, though, given good enough imaging and regular screenings. The imaging...
Exclusive
Your information will never be shared with any third party.